Pharmafile Logo

FDA Map

FDAMAP is a group of global healthcare experts that conducts highly informative conferences, workshops and other training sessions for pharma, diagnostics and medical device industry professionals. Our panels of speakers include experts in clinical trials, data management, statistics, regulatory affairs, safety reporting, pharmacovigilance, social media marketing of medical products (drugs, biologics and medical devices), project management, GMP, GCP GLP, FDA/EMA audits, and information technology. Learn more about our Training and Consultancy Programs (Regulatory Workshops, FDA Seminars and Conferences, and Regulatory Consultancy) on our website www.fdamap.com

We work with professionals, regulators, and government agencies to build unique platforms for consultation, training, networking, and professional development. We strive hard to make high quality, mutually beneficial relationships with our customers and partners alike.

The FDAMap initiative is the newest venture of a group of leading experts from the industry and government to bring professionals at all levels together to create best practices based on logic, logistics, legal, and least-burdensome compliance. Visit: www.fdamap.com

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

20203 Goshen Rd,, Suite 261 Gaithersburg, Gaithersburg, Maryland, MD 20879, United States
+1-410-501-5777

 Latest Content from PMHub 

Bridging the gender health gap: 9 key takeaways from Thrive’s webinar on tech and women’s health

Press Releases | February 25, 2022 | Thrive Agency

Unequal health outcomes have been a reality for women throughout the world for far too long. But change is finally happening.

Bedrock to raise awareness of Rare Disease Day 2022 with film ‘Noah’s Story’

Press Releases | February 25, 2022 | Resonant Group

Emily Wigginton, Bedrock’s Head of Client Services explains the inspiration behind the film.

Eating Disorders Awareness Week

In the latest blog post, Innovative Trials' Equality & Diversity committee focuses on eating disorders

Social Health Prescription: Connecting People, Empowering Patients, & Improving Outcomes

Videos and Podcasts | February 25, 2022 | Impetus Digital

Lynda Brown-Ganzert, Founder & CEO of Curatio, discusses the concept of social health prescription and the inspiration behind Curatio. She also explores questions such as how AI and “intelligent matchmaking” can be leveraged...

A Lucid Group social

The newly formed Lucid Social Committee is launching its first event for the year: Today, on Thursday 24 February Lucid will be hosting its inaugural board games night in both...

Welcome to the era of the orphan drug

As we approach Rare Disease Day on 28 February, we look back at how the rare disease landscape has evolved over the last few decades.

New syndicated patient report – Living with Lupus US

White Papers and Resources | February 23, 2022 | Inizio

Living with Lupus US is a new syndicated patient report which offers valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs.

Launching Health Tech Innovations in the New Normal

Videos and Podcasts | February 17, 2022 | Impetus Digital

Aahuti Rai (Strategic Advisor, Healthcare Innovation at Four Points Consulting) & Jessica Smith (Co-Founder and CXO at SomX) discuss all things HealthTech, including the current barriers to HealthTech commercialization, holistic...

FREE Live Webinar – Diversity in Clinical Trials – 24th February

Innovative Trials, Pfizer and Parexel invite you to attend the live webinar

Three predictions for the clinical trial industry in 2022

Kate Shaw, Innovative Trials Founder & CEO, looks ahead to 2022 by listing three predictions for the clinical trial industry in 2022